FDA Clears Eversense® 365: The World’s First One-Year CGM System
What You Should Know:
– Senseonics Holdings, Inc. and Ascensia Diabetes Care announced that the FDA has cleared the Eversense® 365 CGM system.
– This marks a significant advancement in diabetes management, offering a fully-implantable, long-term…
Continue Reading